FIELD: chemistry.
SUBSTANCE: present invention relates to novel lantibiotic amide derivatives 97518 and use thereof.
EFFECT: present invention describes a compound of general formula (II) 
and use thereof as an antibiotic.
19 cl, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
| COMBINATIONS WHICH INCLUDE RECEPTOR S1P AGONIST AND JAK3 KINASE INHIBITOR | 2005 |
|
RU2415678C2 |
| LIQUID FORMULATIONS | 2006 |
|
RU2470631C2 |
| DERIVATIVES OF AZETHIDINE AS ANTAGONISTS OF CCR-3 RECEPTOR | 2003 |
|
RU2314292C2 |
| METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
| USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
| LIQUID COMPOSITIONS | 2006 |
|
RU2428180C2 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
| METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES BY CERAMIDE DERIVATIVES | 2008 |
|
RU2517345C9 |
| POLYMER-BOUND POLYCYCLIC AROMATIC HYDROCARBONS, CONTAINING NITROGEN-CONTAINING ALTERNATES | 2012 |
|
RU2618748C2 |
